CopyFind
Rosubeat CV 20mg/75mg Capsule

Rosubeat CV 20mg/75mg Capsule

170,00 ₹

Analogs of Rosubeat CV 20mg/75mg Capsule

Find cheaper analogs and generic equivalents for Rosubeat CV 20mg/75mg Capsule.

Ingredients

Principe actif : Rosuvastatin; Clopidogrel


Aperçu du produit

About Rosubeat CV

Rosubeat CV is a medication containing the active ingredient Rosuvastatin, classified as Statin medication. Rosuvastatin, sold under the brand name Crestor among others, is a statin medication, used to prevent cardiovascular disease in those at high risk and treat dyslipidemia or hyperlipidemia. It is recommended to be used with dietary changes, exercise, and weight loss.

Key Benefits & Uses

  • Used for: 1 INDICATIONS AND USAGE Rosuvastatin tablets is indicated: To reduce the risk major adverse cardiovascular (CV) events (CV death, nonfatal myocardial.
  • Use only as directed on the product label or by a healthcare professional.
  • Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Rosuvastatin, the active ingredient in Rosubeat CV, belongs to the Statin medication class. 1 INDICATIONS AND USAGE Rosuvastatin tablets is indicated: To reduce the risk major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, nonfatal stroke, or an arterial revascularization procedure) in adults without established coronary heart disease who are at increased risk of CV disease bas…. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Rosubeat CV. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Rosubeat CV for extended periods without medical advice.

Find in Pharmacies

Compare local prices and distance for Rosubeat CV 20mg/75mg Capsule.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.